VRDN icon

Viridian Therapeutics
VRDN

Overview Fund Activity

27 hedge funds and large institutions have $5.05M invested in Viridian Therapeutics in 2020 Q1 according to their latest regulatory filings, with 11 funds opening new positions, 6 increasing their positions, 3 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
27
Holders Change
+4
Holders Change %
+17.39%
% of All Funds
0.6%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
11
Increased
6
Reduced
3
Closed
6
Calls
$223K
Puts
–
Net Calls
+$223K
Net Calls Change
+$223K

Top Buyers

1
Fidelity Investments
Fidelity Investments
Massachusetts
$1.74M
2
Vanguard Group
Vanguard Group
Pennsylvania
$718K
3
Alyeska Investment Group
Alyeska Investment Group
Illinois
$332K
4
Renaissance Technologies
Renaissance Technologies
New York
$270K
5
Squarepoint
Squarepoint
New York
$30K

Top Sellers

1
6CM
683 Capital Management
New York
$0
2
Millennium Management
Millennium Management
New York
$6K
3
Point72 Asset Management
Point72 Asset Management
Connecticut
$0
4
WS
Wedbush Securities
California
$0
5
Deutsche Bank
Deutsche Bank
Germany
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
6CM
26
683 Capital Management
New York
– -$139K -19,333 Closed
Point72 Asset Management
27
Point72 Asset Management
Connecticut
– -$48K -6,646 Closed
WS
28
Wedbush Securities
California
– -$42K -5,880 Closed
Deutsche Bank
29
Deutsche Bank
Germany
– -$10K -1,424 Closed
Citigroup
30
Citigroup
New York
– -$1K -195 Closed
1
2